Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The crosslinks between ferroptosis and autophagy in asthma. | Front Immunol | 2023 | 37063888 | PubTator, text mining | PubMed |
| New insights into the immune functions of podocytes: the role of complement. | Mol Cell Pediatr | 2023 | 37059832 | PubTator, text mining | PubMed |
| Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37059586 | PubTator, text mining | PubMed |
| High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma. | J Cancer | 2023 | 37057282 | PubTator, text mining | PubMed |
| Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point? | Front Oncol | 2023 | 37056346 | PubTator, text mining | PubMed |
| POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 37047824 | PubTator, text mining | PubMed |
| The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression. | Int J Mol Sci | 2023 | 37047399 | PubTator, text mining | PubMed |
| Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells. | Cardiovasc Diabetol | 2023 | 37046242 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3. | Front Genet | 2023 | 37035741 | PubTator, text mining | PubMed |
| Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation. | Front Immunol | 2023 | 37006317 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis. | Front Immunol | 2023 | 37006311 | PubTator, text mining | PubMed |
| High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis. | Front Genet | 2023 | 36999057 | PubTator, text mining | PubMed |
| Adaptive and innate immune pathogenesis of bullous pemphigoid: A review. | Front Immunol | 2023 | 36993969 | PubTator, text mining | PubMed |
| Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic markings. | Front Immunol | 2023 | 36993968 | PubTator, text mining | PubMed |
| Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients. | Front Pharmacol | 2023 | 36992839 | PubTator, text mining | PubMed |
| Discovery of a Potent and Selective CCR8 Small Molecular Antagonist IPG7236 for the Treatment of Cancer. | J Med Chem | 2023 | 36988587 | PubTator, text mining | PubMed |
| Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis. | Int J Mol Sci | 2023 | 36982834 | PubTator, text mining | PubMed |
| Transcriptomic Studies on Intracranial Aneurysms. | Genes (Basel) | 2023 | 36980884 | PubTator, text mining | PubMed |
| Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. | Cells | 2023 | 36980182 | PubTator, text mining | PubMed |
| ADCY7 mRNA Is a Novel Biomarker in HPV Infection and Cervical High-Grade Squamous Lesions or Higher. | Biomedicines | 2023 | 36979847 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=17